| Literature DB >> 34532264 |
Kunlun He1, Yan Liu1, Dong Li1, Qian Yu1.
Abstract
BACKGROUND: Combination of transurethral resection of the prostate (TURP) and flexible and rigid ureteroscopy (URS/RIRS) is a successful approach for patients with benign prostatic hyperplasia (BPH) and ureteral calculus (UC), and the sequence is URS/RIRS followed by TURP. This research aims to compare TURP followed by URS/RIRS with URS/RIRS followed by TURP in terms of clinical efficiency and safety.Entities:
Keywords: Transurethral resection of the prostate (TURP); benign prostatic hyperplasia (BPH); flexible and rigid ureteroscopy (URS/RIRS); ureteral calculus (UC)
Year: 2021 PMID: 34532264 PMCID: PMC8421826 DOI: 10.21037/tau-21-523
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Figure 1Ureteroscopy was inserted into the bladder through the sheath of the resectoscope.
Figure 2Observation of prostate gland by electrotomy.
Demographic and clinical characteristics of each study group
| Variables | Intervention (n=100), mean ± SD | Control (n=73), mean ± SD | t value | P value |
|---|---|---|---|---|
| Age (years) | 65±5.32 | 64±6.21 | 1.11 | 0.27 |
| BMI (kg/m2) | 24.55±4.32 | 24.36±4.51 | 0.29 | 0.77 |
| Mean ureteral stone diameter (mm) | 7.72±2.63 | 7.25±2.36 | 1.23 | 0.22 |
BMI, body mass index.
Surgical parameters of each study group
| Variables | Intervention (n=100), mean ± SD | Control (n=73), mean ± SD | χ2/t value | P value |
|---|---|---|---|---|
| Success of lithotripsy, n (%) | 95 (95.00) | 70 (95.89) | 0.01 | 1 |
| Operation time (min) | 113.23±12.54 | 118.52±14.63 | −2.49 | 0.01 |
| Length of hospitalization (day) | 8.28±1.54 | 9.99±1.22 | −8.14 | <0.01 |
Urinary function parameters of each study group before and after surgery
| Variables | Intervention (n=100), mean ± SD | Control (n=73), mean ± SD | t value | P value |
|---|---|---|---|---|
| Preoperative | ||||
| IPSS | 25.48±2.65 | 25.37±3.25 | 0.24 | 0.81 |
| QOL | 4.82±0.75 | 4.63±0.74 | 1.66 | 0.09 |
| Qmax | 6.67±1.88 | 7.15±2.16 | −1.52 | 0.13 |
| PVR | 86.85±21.98 | 81.82±14.35 | 1.82 | 0.07 |
| Postoperative after 3 months | ||||
| IPSS | 5.01±1.95 | 5.25±1.82 | −0.83 | 0.41 |
| QOL | 1.23±0.92 | 1.35±0.82 | −0.90 | 0.37 |
| Qmax | 18.13±2.18 | 18.72±2.52 | −1.61 | 0.11 |
| PVR | 21.38±11.85 | 22.64±13.25 | −0.65 | 0.52 |
IPSS, international prostate symptom score; QOL, quality of life; Qmax, maximum flow rate; PVR, post-void residual urine volume.
Complications of each study group
| Variables | Intervention (n=100) | Control (n=73) | χ2 value | P value |
|---|---|---|---|---|
| Intraoperative complications, n | ||||
| TURS | 1 | 2 | 0.08 | 0.78 |
| Blood transfusion | 2 | 2 | 0.01 | 1 |
| Fever | 3 | 7 | 0.23 | 0.64 |
| Urinary tract infection | 4 | 5 | 0.01 | 1 |
| Postoperative complications, n | ||||
| Urinary retention | 1 | 1 | 0.01 | 1 |
| Urethral strictures | 1 | 2 | 0.01 | 1 |
| Recurrence | 1 | 1 | 0.01 | 1 |
TURS, transurethral resection syndrome.